Exclusive

Publication

Byline

China's Hengrui Pharma inks $2.6 B deal with Novo Nordisk for Once-Weekly oral GLP-1/GIP dual receptor agonist HRS-1596

Singapore, Oct. 3 -- China-based Hengrui Pharma has entered into a license agreement with Novo Nordisk for HRS-1596, a phase I-ready glucagon-like peptide-1 receptor (GLP-1R) and gastric inhibitory po... Read More


Toho, Reprocell partner for domestic distribution of regenerative medical product Stemchymal(R) in Japan

Singapore, Oct. 3 -- Reprocell Inc. has entered into a basic agreement with Toho Holdings toward a partnership concerning the domestic distribution and related activities of the regenerative medical p... Read More


Quantum sensing device secures $2.2M funding boost to improve iron diagnosis in Australia

Singapore, Oct. 3 -- New quantum sensing technology that could transform clinical iron testing has received a major funding boost of $2.2 million through the Australian Government's Critical Technolog... Read More


PRECISE and Temus establish Joint Innovation Centre to advance precision health in Singapore

Singapore, Oct. 3 -- Precision Health Research, Singapore (PRECISE), and AI & digital transformation company, Temus, have signed a memorandum of understanding to establish a PRECISE-Temus Joint Innova... Read More


Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs

Singapore, Oct. 3 -- Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio, US. Building on more than seven billion dollars in US pharma R&D a... Read More


High-salt diet may drive fatty liver disease differently in lean people: Duke-NUS pre-clinical study

Singapore, Oct. 1 -- Fatty liver disease is commonly associated with obesity, yet a growing number of people with normal body weight develop a severe form of the condition. Scientists at Duke-NUS Medi... Read More


AABB expands biotherapies coverage with special TRANSFUSION journal supplement

Singapore, Oct. 1 -- The Association for the Advancement of Blood & Biotherapies (AABB) has published a special supplemental issue of its peer-reviewed journal, TRANSFUSION, focused on biotherapies. ... Read More


Vetter expands global manufacturing network with ten additional commercial filling lines

Singapore, Oct. 1 -- Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-and-finish network to further strengthen its global manufactu... Read More


Tamarind Health launches Rare Cancer Centre in Singapore

Singapore, Sept. 30 -- Singapore-based Tamarind Health has announced the launch of its Rare Cancer Centre, bringing together specialist oncologists in rare and complex cancers to make it easier for pa... Read More


Chugai and InxMed enter into worldwide license agreement for RAF-MEK Molecular Glue

Singapore, Sept. 30 -- Japan's Chugai Pharmaceutical and InxMed (Hong Kong) have entered into a worldwide license agreement regarding SPYK04, a RAF-MEK molecular glue discovered by Chugai for the trea... Read More